Sunday, February 5, 2023

No Result

View All Result

Media

No Result

View All Result

Columns

For drug access, Canadians with rare disorders are 40 years behind Americans: Nigel Rawson and John Adams in the Financial Post

January 24, 2023

Nigel Rawson

Can we afford National Pharmacare and do people want it? Jeffrey Simpson for Inside Policy

Columns

PMPRB continues plan to drive down drug prices as patients suffer: Nigel Rawson and John Adams for Inside Policy

November 23, 2022

Build health care back better: Philip Cross in the Financial Post

Columns

Suffer from a rare disorder in Canada? Good luck: Nigel Rawson and John Adams in the Financial Post

November 2, 2022

Columns

Ongoing uncertainty about prices will deter new drug launches in Canada: Nigel Rawson and Brett Skinner in the Hill Times

September 8, 2022

The Patented Medicine Prices Review Board is selling Canadians a lemon: Nigel Rawson for Inside Policy

Health

Ottawa should reset its relationship with drug developers to improve patient health: Rawson and Adams for Inside Policy

May 2, 2022

Health

‘Big Tobacco’ COVID-19 vaccine: What were the Liberals thinking? Nigel Rawson and John Adams for the Financial Post

April 22, 2022

Domestic Policy Program

The Macdonald-Laurier Institute Welcomes Newest Senior Fellows, Nigel Rawson and John Adams

April 11, 2022

Macdonald-Laurier Institute

Follow us on

Newsletter Signup

Support Us

Support the Macdonald-Laurier Institute to help ensure that Canada is one of the best governed countries in the world. Click below to learn more or become a sponsor.

Support Us

Inside Policy Magazine

No Result

View All Result

For drug access, Canadians with rare disorders are 40 years behind Americans: Nigel Rawson and John Adams in the Financial Post

Nigel Rawson

PMPRB continues plan to drive down drug prices as patients suffer: Nigel Rawson and John Adams for Inside Policy

Suffer from a rare disorder in Canada? Good luck: Nigel Rawson and John Adams in the Financial Post

Ongoing uncertainty about prices will deter new drug launches in Canada: Nigel Rawson and Brett Skinner in the Hill Times

Ottawa should reset its relationship with drug developers to improve patient health: Rawson and Adams for Inside Policy

‘Big Tobacco’ COVID-19 vaccine: What were the Liberals thinking? Nigel Rawson and John Adams for the Financial Post

The Macdonald-Laurier Institute Welcomes Newest Senior Fellows, Nigel Rawson and John Adams

Top News

Stronger enforcement of the Competition Act is better than a dramatic overhaul

Most Canadians think prisons should continue to house male and female prisoners separately

Webinar panel video: Defending democracies from disinformation – A new imperative for Canada-Japan strategic cooperation

Multimedia

An armchair discussion with Keir Giles, author of Russia’s War on Everybody: And What it Means for You

Webinar panel video: Race to resources? Canada’s new critical minerals strategy and its implications

The F-35 Saga: Richard Shimooka with Christoph Bergs on Military Aviation History

What China’s zero-COVID approach taught us about compassion: Sandra Rao for Inside Policy

Shuvaloy Majumdar passes the baton at MLI

Canada’s fighter jet debacle is a costly ode to unseriousness: Richard Shimooka in the Hub

COVID vaccine mandates in Canada were a mistake: Are we ready to learn the right lessons?

Long live the king: Why a constitutional monarchy is an ideal system for Canada – F. H Buckley for Inside Policy

Macdonald-Laurier Institute

Follow us on

Newsletter Signup

Support Us

Inside Policy Magazine